SynZeal Research PVT LTD
All Categories
  • All Categories
  • Accessories
  • Accessories & More
  • Butters & Eggs
  • Camera & Video
  • Mornitors
  • Tablets
  • Laptops
  • Handbags
  • Headphone & Speaker
  • Herbs & botanicals
  • Vegetables
  • Shop
  • Laptops & Desktops
  • Watchs
  • Electronic

Phenazopyridine Related Products

SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Phenazopyridine, pharmacopeial and non-pharmacopeial Phenazopyridine impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Phenazopyridine impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Phenazopyridine-related products are thoroughly characterized. Phenazopyridine products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.

目录编号: SZ-P085001
CAS 号: 136-40-3
分子式 : C11H11N5 : HCl
分子量 : 213.2 : 36.5
投资状态: Custom Synthesis
Rel. CAS No : 94-78-0 (free base)
SZ-P085001
CAS No:136-40-3
分子式: C11H11N5 : HCl
分子量: 213.2 : 36.5
投资状态: Custom Synthesis
Rel. CAS No : 94-78-0 (free base)
目录编号: SZ-P085002
CAS 号: 141-86-6
分子式 : C5H7N3
分子量 : 109.1
投资状态: Custom Synthesis
Rel. CAS No : 26878-34-2 (HCl salt) ; 2566700-98-7 (HBr salt)
SZ-P085002
CAS No:141-86-6
分子式: C5H7N3
分子量: 109.1
投资状态: Custom Synthesis
Rel. CAS No : 26878-34-2 (HCl salt) ; 2566700-98-7 (HBr salt)
目录编号: SZ-P085003
CAS 号: 1168133-05-8
分子式 : C17H15N5
分子量 : 289.3
投资状态: Custom Synthesis
SZ-P085003
CAS No:1168133-05-8
分子式: C17H15N5
分子量: 289.3
投资状态: Custom Synthesis
目录编号: SZ-P085005
CAS 号: NA
分子式 : C17H15N7
分子量 : 317.4
投资状态: Custom Synthesis
SZ-P085005
CAS No:NA
分子式: C17H15N7
分子量: 317.4
投资状态: Custom Synthesis